Evidence map›Paper›PMID 32349282›Full record

ReviewMolecules (Basel, Switzerland)2020

Beneficial Impact of Semicarbazide-Sensitive Amine Oxidase Inhibition on the Potential Cytotoxicity of Creatine Supplementation in Type 2 Diabetes Mellitus.

Dimitri Papukashvili, Nino Rcheulishvili, Yulin Deng

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Self-Amplifying RNA Approach for Protein Replacement Therapy.International journal of molecular sciences · 2022
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dimitri PapukashviliSchool of Life Science, Beijing Institute of Technology, Beijing 100081, China.
Nino RcheulishviliSchool of Life Science, Beijing Institute of Technology, Beijing 100081, China.
Yulin DengSchool of Life Science, Beijing Institute of Technology, Beijing 100081, China.
Beijing Institute of Technology · CN

Funding

THE RESEARCH AND DEVELOPMENT OF DIGITAL DIAGNOSIS AND TREATMENT EQUIPMENT GRANT 2017YFC0108504
6 · The paper itself

Abstract

Creatine supplementation of the population with type 2 diabetes mellitus (T2DM) combined with an exercise program is known to be a possible therapy adjuvant with hypoglycemic effects. However, excessive administration of creatine leads to the production of methylamine which is deaminated by the enzyme semicarbazide-sensitive amine oxidase (SSAO) and as a result, cytotoxic compounds are produced. SSAO activity and reaction products are increased in the serum of T2DM patients. Creatine supplementation by diabetics will further augment the activity of SSAO. The current review aims to find a feasible way to ameliorate T2DM for patients who exercise and desire to consume creatine. Several natural agents present in food which are involved in the regulation of SSAO activity directly or indirectly are reviewed. Particularly, zinc-α2-glycoprotein (ZAG), zinc (Zn), copper (Cu), histamine/histidine, caffeine, iron (Fe), and vitamin D are discussed. Inhibiting SSAO activity by natural agents might reduce the potential adverse effects of creatine metabolism in population of T2DM.

Indexed as

AdipokinesAmine Oxidase (Copper-Containing)CaffeineCopperCreatineDiabetes Mellitus, Type 2HistamineHistidineHumansIronVitamin DZincZn-Alpha-2-GlycoproteinAdipokinesAmine Oxidase (Copper-Containing)AZGP1 protein, humanCaffeineCopperCreatineHistamineHistidineIronVitamin DZincZn-Alpha-2-GlycoproteincaffeinecreatineCuFehistamine/histidineSSAOT2DMvitamin DZAG/Zn

Identifiers

PMID32349282
PMCPMC7248702
OpenAlexW3019995439

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.